Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome

Area of Science:

• Endocrinology
• Neuroscience
• Psychiatry

Background:

• Chronic fatigue syndrome (CFS) is a complex, debilitating disorder.
• Hypothalamic-pituitary-adrenal (HPA) axis dysfunction is frequently observed in CFS patients.
• Previous research suggests a link between HPA axis alterations and CFS symptoms.

Purpose of the Study:

• To synthesize current evidence on HPA axis dysfunction in CFS.
• To explore the clinical relevance and potential etiological factors of HPA axis changes in CFS.
• To guide future research directions for understanding and managing HPA axis dysfunction in CFS.

Main Methods:

• Systematic review and meta-analysis of existing literature on HPA axis function in CFS.
• Analysis of cortisol levels, diurnal variation, and feedback mechanisms.
• Correlation of HPA axis parameters with clinical symptoms, disability, and treatment outcomes.

Main Results:

• Consistent evidence supports HPA axis dysfunction in CFS, including hypocortisolism, blunted diurnal variation, and altered feedback sensitivity.
• HPA axis alterations are clinically significant, associated with increased symptom severity, disability, and poorer treatment response.
• Factors such as female sex, low activity, depression, early-life stress, and psychotropic medication use influence cortisol levels in CFS.

Conclusions:

• HPA axis dysfunction is a key feature of CFS with clinical implications.
• A multifactorial model integrating biological and psychosocial factors is crucial for understanding HPA axis changes in CFS.
• Cognitive behavioral therapy shows promise for improving HPA axis function, while steroid replacement is not recommended; further research is needed to elucidate the precise causes and relevance of these changes.